Bone-marrow transplantation (second of two parts).
D000380:Agranulocytosis / Q000150:complications; D000741:Anemia, Aplastic / Q000628:therapy; D000818:Animals; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002471:Cell Transformation, Neoplastic; D003586:Cytomegalovirus Infections / Q000209:etiology; D004285:Dogs; D006084:Graft Rejection; D006087:Graft vs Host Reaction / Q000187:drug effects; D006648:Histocompatibility; D006801:Humans; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D007239:Infections / Q000209:etiology; D007938:Leukemia / Q000628:therapy; D007958:Leukocyte Count; D051379:Mice; D011183:Postoperative Complications; D012106:Research; D014019:Tissue Donors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous